XML 75 R65.htm IDEA: XBRL DOCUMENT v3.24.3
Equity - Summary of the Warrants (Details) - $ / shares
Mar. 31, 2024
Mar. 13, 2024
Stockholders Equity Details [Line Items]    
Number of shares 10,905,901  
Exercise price   $ 8.1
Dragasac Warrant    
Stockholders Equity Details [Line Items]    
Number of shares [1] 652,981  
Exercise price [1] $ 2.4898  
Expiration date [1] Mar. 16, 2025  
Public Warrants    
Stockholders Equity Details [Line Items]    
Number of shares [2] 1,437,447  
Exercise price [2] $ 115  
Expiration date [2] Jul. 16, 2026  
Sponsor Warrants    
Stockholders Equity Details [Line Items]    
Number of shares [2] 849,999  
Exercise price [2] $ 115  
Expiration date [2] Jul. 16, 2026  
May 2022 PIPE Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 405,405  
Exercise price $ 3.5  
Expiration date Oct. 10, 2028  
March 2023 PIPE Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 208,485  
Exercise price $ 30  
Expiration date Mar. 27, 2028  
March 2023 PIPE Warrants (modified)    
Stockholders Equity Details [Line Items]    
Number of shares 729,698  
Exercise price $ 10  
Expiration date Mar. 27, 2028  
March 2023 Loan Warrants    
Stockholders Equity Details [Line Items]    
Number of shares [3] 75,000  
Exercise price [3] $ 5.895  
Expiration date [3] Mar. 17, 2028  
April 2023 Registered Direct Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 435,625  
Exercise price $ 7.5  
Expiration date Oct. 10, 2028  
April 2023 Registered Direct Warrants (Modified)    
Stockholders Equity Details [Line Items]    
Number of shares 487,451  
Exercise price $ 3.5  
Expiration date Oct. 10, 2028  
May 2023 PIPE Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 581,394  
Exercise price $ 10  
Expiration date May 17, 2028  
June 2023 Warrants    
Stockholders Equity Details [Line Items]    
Number of shares [3] 50,000  
Exercise price [3] $ 5.895  
Expiration date [3] Jun. 20, 2028  
June 2023 Loan Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 300,000  
Exercise price $ 8.1  
Expiration date Jun. 20, 2028  
July 2023 Registered Direct Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 857,142  
Exercise price $ 3.5  
Expiration date Jan. 31, 2029  
January 2024 PIPE Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 535,274  
Exercise price $ 2.4898  
Expiration date Jan. 16, 2029  
January 2024 Bridge Loan - Tranche #1 Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 1,650,000  
Exercise price $ 2.4898  
Expiration date Jan. 16, 2029  
January 2024 Bridge Loan - Tranche #2 Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 1,350,000  
Exercise price $ 3.076  
Expiration date Jul. 17, 2029  
March 2024 RWI Forbearance Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 300,000  
Exercise price $ 5.895  
Expiration date Jun. 20, 2028  
[1] In connection with the execution of the January 2024 PIPE described above, the Company agreed to reprice 652,981 legacy warrants held by Dragasac with a previous exercise price of $67.70 to a new exercise price of $2.4898. The term of the warrants was unchanged.
[2] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.
[3] In connection with the execution of the Starr Forbearance Agreement on March 13, 2024, described above under Warrant Modification and further in Note 7, the Company agreed to reprice 75,000 warrants with a previous exercise price of $7.10 and 50,000 warrants with a previous exercise price of $8.10 held by C.V. Starr to a new exercise price of $5.895. The term of the warrants was unchanged.